Search - tctmd.com

Displaying 521 - 540 of 757

Sort: Relevancy | Date

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Conference News TCT 2015

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Yael L. Maxwell

October 12, 2015

News Industry News

Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting

October 11, 2015

News Industry News

Tamir Wolf, MD, PhD Joins the Cardiovascular Research Foundation as Senior Director, Operations and Development for the CRF Clinical Trials Center

October 08, 2015

News Industry News

Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies

October 08, 2015

News Industry News

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

October 05, 2015

News Daily News

Un Estudio Avala la CABG Multiarterial para el Manejo de la EAC Multivaso

Todd Neale

September 24, 2015

News Daily News

Study Supports Multiarterial CABG for Multivessel CAD

Todd Neale

September 24, 2015

News Industry News

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

September 23, 2015

News Industry News

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

September 14, 2015

News Daily News

在经股 TAVR 后切口部位缝合方面 ProGlide 优于 Prostar XL

September 09, 2015

News Daily News

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

September 09, 2015

News Daily News

ProGlide Supera a Prostar XL en el Cierre del Sitio de Acceso para la TAVR Transfemoral

September 09, 2015

News Industry News

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

August 27, 2015

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

News Industry News

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

July 27, 2015

News Daily News

In Medicare Population, Early Survival Benefit of EVAR Lost After 3 Years

July 23, 2015

News Daily News

En la Población de Medicare, el Beneficio Precoz sobre la Supervivencia que ofrece EVAR Desaparece a los 3 Años

July 23, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Yael L. Maxwell

July 15, 2015

Advertisement

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting

Tamir Wolf, MD, PhD Joins the Cardiovascular Research Foundation as Senior Director, Operations and Development for the CRF Clinical Trials Center

Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

Un Estudio Avala la CABG Multiarterial para el Manejo de la EAC Multivaso

Study Supports Multiarterial CABG for Multivessel CAD

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

在经股 TAVR 后切口部位缝合方面 ProGlide 优于 Prostar XL

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

ProGlide Supera a Prostar XL en el Cierre del Sitio de Acceso para la TAVR Transfemoral

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

In Medicare Population, Early Survival Benefit of EVAR Lost After 3 Years

En la Población de Medicare, el Beneficio Precoz sobre la Supervivencia que ofrece EVAR Desaparece a los 3 Años

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content